Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
3.09T | 1.56T | 1.15T | 1.14T | 1.24T | 1.07T | Gross Profit |
77.56B | -1.23T | -181.27B | 748.88B | 853.11B | 238.44B | EBIT |
328.53B | 795.54B | 1.30T | 453.19B | 223.39B | 245.89B | EBITDA |
882.49B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
211.47B | 165.86B | 92.79B | 143.00B | 153.12B | 217.00B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.55T | 4.24T | 4.52T | 3.64T | 4.16T | 3.87T | Total Assets |
43.49T | 55.15T | 47.77T | 43.41T | 42.52T | 44.00T | Total Debt |
9.35T | 14.09T | 11.74T | 10.90T | 9.94T | 10.17T | Net Debt |
6.79T | 8.93T | 7.22T | 6.84T | 5.78T | 6.30T | Total Liabilities |
40.66T | 51.70T | 44.55T | 40.44T | 39.76T | 41.27T | Stockholders Equity |
2.80T | 3.35T | 3.15T | 2.91T | 2.69T | 2.65T |
Cash Flow | Free Cash Flow | ||||
466.93B | -13.14B | -1.15T | -1.48T | 545.89B | -222.69B | Operating Cash Flow |
591.09B | 132.64B | -974.75B | -1.37T | 665.77B | -15.94B | Investing Cash Flow |
-1.19T | -887.94B | 38.95B | -45.30B | -139.03B | 216.34B | Financing Cash Flow |
793.38B | 1.01T | 1.29T | 1.07T | -269.93B | 332.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $31.11B | 26.92 | 40.36% | 0.31% | 26.32% | 8.63% | |
73 Outperform | $29.61B | 14.14 | 18.84% | 1.29% | 11.79% | 25.74% | |
71 Outperform | $211.48B | 15.47 | 13.88% | 2.81% | 6.53% | 55.54% | |
67 Neutral | $10.81B | 18.16 | 6.38% | 2.86% | 16.62% | 139.24% | |
66 Neutral | $188.40B | 14.25 | 12.26% | 1.95% | 7.70% | 68.64% | |
64 Neutral | $12.85B | 9.81 | 7.59% | 16985.65% | 12.30% | -7.71% | |
61 Neutral | $18.24B | 8.57 | 9.88% | 6.26% | 8.32% | 100.90% |